Position in IBRX
as of Mar 31, 2026
· filed Jun 30, 2026
Position Value
$5,540,600
+$4,110,302 QoQ
Shares Held
722,373
0.0% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
5.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 77.0151985193245.ToString("F0")%
Shared 0.ToString("F0")%
None 22.984801480675497.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Winning Points Advisors, LLC holds $5,540,600 across 1 Biotechnology name. IBRX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
This page
|
722,373 | $5,540,600 |
All Filings in IBRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,540,600 | 722,373 | Shares | Sole | 2026-06-30 | |
| 2025-12-31 | $1,430,298 | 722,373 | Shares | Sole | 2026-02-12 | |
| 2024-09-30 | $332,553 | 89,396 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $498,260 | 92,786 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $465,785 | 92,786 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $151,079 | 89,396 | Shares | Sole | 2024-11-14 | |
| 2023-06-30 | $257,945 | 92,786 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $457,158 | 251,186 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,229,911 | 242,586 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,250,233 | 251,556 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $881,476 | 236,956 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $337,306 | 60,126 | Shares | Sole | 2022-04-27 | |
| 2021-09-30 | $428,150 | 43,958 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $592,263 | 41,475 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $949,600 | 40,000 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||